Sky View Investment Advisors, LLC Organon & Co. Transaction History

Sky View Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$19.27 - $24.63 $57 - $73	3 Added 12.0%	28 $1,000
Q1 2023 May 18, 2023	SELL	$21.42 - $32.08 $21 - $32	-1 Reduced 3.85%	25 $1,000
Q2 2022 Nov 15, 2022	SELL	$31.66 - $38.9 $296,907 - $364,804	-9,378 Reduced 99.72%	26 $1,000
Q1 2022 May 17, 2022	BUY	$30.45 - $39.36 $221,432 - $286,225	7,272 Added 341.09%	9,404 $328,000
Q4 2021 Feb 18, 2022	BUY	$28.67 - $37.13 $61,124 - $79,161	2,132 New	2,132 $262,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky View Investment Advisors, LLC with notifications on news.